Amsterdam, Netherlands

Max Nieuwdorp

This inventor holds 4 USPTO granted patents and 4 published patent applications, plus 1 CIPO patent and 4 EPO patents. Top assignees: Academisch Medisch Centrum, Caelus Pharmaceuticals B.v., Wageningen Unlversiteit. Active years: 2016-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Max Nieuwdorp. Retrieved from https://idiyas.com/inventor/max-nieuwdorp

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 4 

% Patents Active = 100.0

 

 

Average Co-Inventor Count = 2.0

ph-index = 2

Forward Citations = 43(Granted Patents)


Company Filing History:


Years Active: 2016-2026

Loading Chart...
Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: Max Nieuwdorp: Innovator in Medical Treatments

Introduction

Max Nieuwdorp is a prominent inventor based in Amsterdam, Netherlands. He has made significant contributions to the field of medical treatments, particularly in the areas of autoimmune diseases and insulin resistance. With a total of three patents to his name, Nieuwdorp is recognized for his innovative approaches to health and medicine.

Latest Patents

Nieuwdorp's latest patents include groundbreaking methods for treating autoimmune diseases and preventing insulin resistance. One of his notable patents involves the use of autologous fecal matter in the treatment of autoimmune diseases. This method focuses on administering fecal matter that is specific to the subject, particularly targeting the small intestine. The constituents of this fecal matter can include a variety of biological elements such as bacteria, viruses, and proteins.

Another significant patent describes a method for preventing and treating insulin resistance. This invention outlines the use of specific bacteria as a medicament to combat insulin resistance and related complications, including metabolic syndrome and type 2 diabetes. The method emphasizes increasing the levels of these beneficial bacteria in the small intestine to improve health outcomes for individuals suffering from these conditions.

Career Highlights

Throughout his career, Max Nieuwdorp has worked with esteemed organizations such as Academisch Medisch Centrum and Caelus Pharmaceuticals. His work in these institutions has allowed him to develop and refine his innovative ideas, contributing to advancements in medical science.

Collaborations

Max Nieuwdorp has collaborated with notable professionals in his field, including Willem Meindert De Vos. These partnerships have facilitated the exchange of ideas and expertise, further enhancing the impact of his inventions.

Conclusion

Max Nieuwdorp stands out as a key figure in the realm of medical innovation. His patents reflect a commitment to improving health through scientific advancements. His work continues to inspire future research and development in the medical field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…